PDF Cover

Gamma Knife Radiosurgery Market

The market for Gamma Knife Radiosurgery was estimated at $812 million in 2024; it is anticipated to increase to $1.25 billion by 2030, with projections indicating growth to around $1.78 billion by 2035.

Report ID:DS1801249
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Gamma Knife Radiosurgery
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Gamma Knife Radiosurgery Market Outlook

Revenue, 2024

$812M

Forecast, 2034

$1.66B

CAGR, 2025 - 2034

7.4%

The Gamma Knife Radiosurgery industry revenue is expected to be around $872.4 million in 2025 and expected to showcase growth with 7.4% CAGR between 2025 and 2034. Building on this steady growth trajectory, the gamma knife radiosurgery market is gaining increasing clinical and commercial importance as healthcare systems prioritize precision-based, minimally invasive treatments for neurological disorders. The rising global incidence of brain tumors, metastases, and functional neurological conditions is a key factor driving demand. Additionally, advancements in image-guided radiation therapy and growing preference for outpatient procedures are enhancing adoption across specialized treatment centers. Hospitals are investing in advanced radiosurgery platforms to improve patient outcomes, reduce hospital stays, and optimize operational efficiency. Expanding healthcare infrastructure in emerging economies and increasing awareness among patients and clinicians are further reinforcing the market’s relevance within modern neuro-oncology and neurosurgical care.

Gamma knife radiosurgery is a non-invasive stereotactic radiosurgery technique that uses highly focused gamma radiation beams to treat abnormalities within the brain without the need for traditional surgery. It is primarily used for conditions such as brain tumors, arteriovenous malformations, trigeminal neuralgia, and certain functional disorders. The technology delivers precise radiation doses while minimizing damage to surrounding healthy tissue, making it highly effective and safe. Recent innovations, particularly in advanced systems such as Icon, have introduced image guidance, motion tracking, and frameless treatment capabilities, improving patient comfort and treatment flexibility. Increasing adoption of these next-generation systems, along with the growing trend toward precision medicine and targeted therapies, is significantly driving demand in the global gamma knife radiosurgery market.

Gamma Knife Radiosurgery market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Gamma Knife Radiosurgery Market Outlook

Market Key Insights

  • The Gamma Knife Radiosurgery market is projected to grow from $812.3 million in 2024 to $1.66 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Brain Metastasis Treatment, Treatment of Arteriovenous Malformations, and Trigeminal Neuralgia Management.

  • Elekta AB, Varian Medical Systems Inc, and Brainlab AG are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Japan are the top markets within the Gamma Knife Radiosurgery market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.

  • Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.

  • Transition like Transition from invasive neurosurgery to non invasive precision radiosurgery treatments is expected to add $106 million to the Gamma Knife Radiosurgery market growth by 2030.

  • The Gamma Knife Radiosurgery market is set to add $846 million between 2024 and 2034, with manufacturer targeting Specialized Clinics & Cancer Research Institutes Application projected to gain a larger market share.

  • With

    rise in brain tumor cases, and

    Advancements in Technology, Gamma Knife Radiosurgery market to expand 104% between 2024 and 2034.

gamma knife radiosurgery market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Gamma Knife Radiosurgery - Country Share Analysis

Opportunities in the Gamma Knife Radiosurgery

There is also a growing opportunity for gamma knife radiosurgery in managing functional neurological disorders such as trigeminal neuralgia and movement disorders. Increasing awareness among neurologists and patients about non invasive treatment options is driving adoption. Advanced systems enable precise targeting of neural pathways, offering effective symptom relief with minimal risk. This trend is gaining traction in regions with aging populations, including Europe and Japan. Functional disorder applications are expected to grow steadily, supported by clinical research advancements and increasing demand for non surgical neurological treatments.

Growth Opportunities in North America and Asia Pacific

North America represents a leading market for gamma knife radiosurgery, driven by advanced healthcare infrastructure, high adoption of precision medicine, and strong presence of specialized neurosurgical centers. The region benefits from increasing incidence of brain tumors and metastases, which continues to drive demand for non invasive treatment options. Key opportunities lie in the expansion of outpatient radiosurgery centers and the growing adoption of advanced systems such as Icon, which support frameless and fractionated treatments. Favorable reimbursement frameworks and ongoing investments in healthcare technology further strengthen market growth. However, competition is intense, with alternative radiosurgery technologies such as linear accelerator-based systems influencing purchasing decisions. Leading hospitals are focusing on technological upgrades and clinical differentiation to maintain competitive advantage, driving continuous innovation and adoption.
Asia Pacific is emerging as a high growth region for gamma knife radiosurgery, supported by rapid healthcare infrastructure development and increasing cancer burden across countries such as China, India, and Japan. Rising awareness of minimally invasive treatments and expanding access to advanced diagnostic technologies are key growth drivers. Significant opportunities exist in the installation of new gamma knife systems in tertiary care hospitals and oncology centers, particularly in urban areas. Government initiatives and private investments in healthcare are accelerating adoption. However, the market remains highly price sensitive, with competition influenced by cost considerations and alternative treatment options. Despite this, increasing patient volumes and improving healthcare accessibility are expected to drive sustained demand in the region.

Market Dynamics and Supply Chain

01

Driver: Rising incidence of brain disorders and increasing demand for minimally invasive treatments

The growing global burden of neurological disorders such as brain tumors, metastases, and vascular malformations is also a major driver for the gamma knife radiosurgery market. Increasing cancer prevalence, particularly secondary brain metastases, is also creating strong demand for precise and effective treatment options. At the same time, there is also a clear shift toward minimally invasive procedures that reduce hospital stays, surgical risks, and recovery time. Gamma knife radiosurgery meets these requirements by offering non invasive, outpatient-based treatment with high precision. This dual trend is also further supported by improving healthcare access and rising patient awareness, leading to wider adoption across both developed and emerging healthcare systems.
Technological innovation in gamma knife systems is also significantly driving market growth, particularly through advancements in image guidance and motion management. Next-generation platforms such as Icon enable real time imaging and frameless treatment, allowing greater patient comfort and expanded clinical applications. These improvements support fractionated radiosurgery, enabling treatment of larger or more complex lesions that were also previously difficult to manage. Hospitals are also increasingly investing in these advanced systems to enhance clinical outcomes and operational efficiency. This trend is also strengthening the competitive positioning of gamma knife radiosurgery within the broader stereotactic radiosurgery market.
02

Restraint: High capital investment and limited accessibility restricting adoption in emerging healthcare markets

One of the most significant restraints in the gamma knife radiosurgery market is the high capital investment required for system installation and maintenance, which limits adoption across smaller hospitals and developing regions. Advanced systems involve substantial upfront costs, specialized infrastructure, and ongoing maintenance expenses, making them financially unviable for many healthcare providers. For example, hospitals in resource-constrained regions often prioritize more versatile radiotherapy equipment, reducing demand for dedicated gamma knife systems. This leads to uneven market penetration, with revenue concentrated in large urban centers while limiting broader global expansion and patient access.
03

Opportunity: Rising demand for brain metastasis treatment in Asia Pacific oncology hospitals and Expanding adoption of Icon systems in outpatient neurosurgery centers globally

Increasing cancer incidence and improving diagnostic capabilities in Asia Pacific are driving demand for gamma knife radiosurgery in brain metastasis treatment. Oncology hospitals in countries such as China and India are expanding their radiotherapy infrastructure to manage growing patient volumes. Gamma knife systems, especially Perfexion and Icon, are being adopted for their precision in treating multiple lesions. Government investments and private sector participation in healthcare infrastructure are further supporting this growth. Brain metastasis applications are expected to dominate due to the rising prevalence of secondary brain tumors in the region.
The shift toward outpatient care is creating a strong opportunity for Icon-based gamma knife radiosurgery systems in specialized neurosurgery centers. These systems enable frameless and fractionated treatments, allowing greater flexibility and reduced hospital stays. Outpatient facilities are increasingly investing in advanced radiosurgery to improve patient throughput and cost efficiency. This trend is particularly evident in developed regions such as North America and Europe, where healthcare systems emphasize minimally invasive and day-care procedures. Icon systems are expected to witness the fastest growth due to their adaptability and patient-centric features.
04

Challenge: Reimbursement challenges and competition from alternative radiosurgery technologies reducing demand growth

Inconsistent reimbursement policies and competition from alternative treatment technologies are actively constraining market expansion. Many healthcare systems do not provide adequate or uniform coverage for gamma knife procedures, increasing out-of-pocket costs and discouraging patient adoption. Additionally, alternatives such as linear accelerator-based radiosurgery and proton therapy offer comparable outcomes with greater versatility, influencing provider preference. For instance, hospitals may opt for multi-purpose radiotherapy systems instead of gamma knife units to maximize utilization, which reduces purchasing demand and intensifies competitive pressure, ultimately impacting revenue growth and long-term market dynamics.

Supply Chain Landscape

1

Raw Material Procurement

H C-StarckATI Metals
2

Equipment Manufacturing

ElektaVarian Medical Systems
3

Distribution & Sales

Alpha Omega Services IncMUDr. Doleal
4

End-Users

Hospitals and ClinicsSpecialist Neurosurgery Centers
Gamma Knife Radiosurgery - Supply Chain

Use Cases of Gamma Knife Radiosurgery in Brain Metastasis Treatment & Treatment of Arteriovenous Malformations

Brain Metastasis Treatment : In brain metastasis treatment, gamma knife radiosurgery is most commonly performed using advanced systems such as Icon and Perfexion due to their ability to deliver highly precise, image guided radiation to multiple lesions in a single session. These systems are widely used in hospitals and specialized oncology centers to manage metastatic brain tumors without invasive surgery. The key advantage lies in treating small and multiple tumors with minimal damage to surrounding healthy tissue, reducing recovery time and improving patient quality of life. Increasing cancer incidence and preference for non invasive treatments are significantly driving adoption in this application.
Treatment of Arteriovenous Malformations : In the treatment of arteriovenous malformations, gamma knife radiosurgery is primarily utilized through frame based systems such as Perfexion, which ensure sub millimeter accuracy during radiation delivery. This application requires extreme precision to target abnormal blood vessel tangles in the brain while avoiding critical surrounding structures. The procedure works by gradually causing the abnormal vessels to thicken and close off over time. Its non invasive nature makes it an effective alternative to open surgery, especially for deep or inoperable lesions. Growing clinical preference for safer treatment options is supporting its continued use in vascular disorder management.
Trigeminal Neuralgia Management : In trigeminal neuralgia management, gamma knife radiosurgery is typically performed using both Perfexion and Icon systems, with increasing adoption of frameless Icon technology for enhanced patient comfort. The treatment focuses on delivering a targeted radiation dose to the trigeminal nerve root to reduce pain signals. This approach is particularly beneficial for patients who are not suitable candidates for invasive surgery or have not responded to medication. The key advantage is significant pain relief with minimal risk and outpatient convenience. Rising cases of neurological pain disorders and demand for non invasive pain management solutions are driving growth in this segment.

Impact of Industry Transitions on the Gamma Knife Radiosurgery Market

As a core segment of the Medical Device industry, the Gamma Knife Radiosurgery market develops in line with broader industry shifts. Over recent years, transitions such as Transition from invasive neurosurgery to non invasive precision radiosurgery treatments and Shift from frame based systems to frameless image guided radiosurgery technologies have redefined priorities across the Medical Device sector, influencing how the Gamma Knife Radiosurgery market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Transition from invasive neurosurgery to non invasive precision radiosurgery treatments

The gamma knife radiosurgery market is undergoing a significant shift from traditional open neurosurgical procedures to non invasive, high precision radiosurgery. Hospitals and neurosurgeons are increasingly preferring gamma knife systems for treating brain tumors and vascular disorders due to reduced surgical risks, shorter recovery times, and improved patient outcomes. For example, patients with brain metastases are now frequently treated in outpatient settings instead of undergoing complex surgeries. This transition is reducing hospital stays and overall treatment costs while increasing patient throughput, thereby improving operational efficiency across neurology and oncology care centers.
02

Shift from frame based systems to frameless image guided radiosurgery technologies

Another key transition is the movement from conventional frame based gamma knife systems to advanced frameless, image guided technologies such as Icon. These systems enhance patient comfort by eliminating rigid head frames and enabling mask based treatments. For instance, hospitals are increasingly adopting frameless systems to offer fractionated therapy for complex or larger lesions. This transition is expanding the scope of treatable conditions and improving workflow flexibility. It is also driving system upgrades and replacement demand, encouraging healthcare providers to invest in next generation platforms to remain competitive and technologically advanced.